Polybrominated Diphenyl Ethers (PBDEs) and Human Health: Effects on Metabolism, Diabetes and Cancer-Reference-Cited by-同舟云学术

Polybrominated Diphenyl Ethers (PBDEs) and Human Health: Effects on Metabolism, Diabetes and Cancer

Published:2023-08-24 Issue:17 Volume:15 Page:4237
ISSN:2072-6694
Container-title:Cancers
language:en
Short-container-title:Cancers

Author:

Renzelli Valerio¹,Gallo Marco²^ORCID,Morviducci Lelio³,Marino Giampiero⁴,Ragni Alberto²,Tuveri Enzo⁵,Faggiano Antongiulio⁶^ORCID,Mazzilli Rossella⁶,Natalicchio Annalisa⁷^ORCID,Zatelli Maria Chiara⁸^ORCID,Montagnani Monica⁹^ORCID,Fogli Stefano¹⁰,Giuffrida Dario¹¹^ORCID,Argentiero Antonella¹²,Danesi Romano¹⁰^ORCID,D’Oronzo Stella¹³^ORCID,Gori Stefania¹⁴^ORCID,Franchina Tindara¹⁵^ORCID,Russo Antonio¹⁶,Monami Matteo¹⁷^ORCID,Sciacca Laura¹⁸^ORCID,Cinieri Saverio¹⁹,Colao Annamaria²⁰²¹,Avogaro Angelo²²,Di Cianni Graziano²³,Giorgino Francesco⁷^ORCID,Silvestris Nicola¹⁵

Affiliation:

1. Italian Association of Clinical Diabetologists, 00192 Rome, Italy

2. Endocrinology and Metabolic Diseases Unit, AO SS Antonio e Biagio e Cesare Arrigo of Alessandria, 15121 Alessandria, Italy

3. Diabetology and Nutrition Unit, Department of Medical Specialities, ASL Roma 1, S. Spirito Hospital, 00193 Rome, Italy

4. Internal Medicine Department, Ospedale dei Castelli, Asl Roma 6, 00040 Ariccia, Italy

5. Diabetology, Endocrinology and Metabolic Diseases Service, ASL-Sulcis, 09016 Iglesias, Italy

6. Endocrinology Unit, Department of Clinical & Molecular Medicine, Sant’Andrea Hospital, Sapienza University of Rome, 00189 Rome, Italy

7. Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, 70121 Bari, Italy

8. Section of Endocrinology, Geriatrics and Internal Medicine, Department of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy

9. Department of Precision and Regenerative Medicine and Ionian Area, Section of Pharmacology, University of Bari Aldo Moro, 70121 Bari, Italy

10. Clinical Pharmacology and Pharmacogenetics Unit, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy

11. Department of Oncology, Istituto Oncologico del Mediterraneo, Viagrande, 95029 Catania, Italy

12. Medical Oncology Unit, IRCCS Istituto Tumori “Giovanni Paolo II”, 70124 Bari, Italy

13. Interdisciplinary Department of Medicine, University of Bari Aldo Moro, 70121 Bari, Italy

14. Oncologia Medica, IRCCS Ospedale Don Calabria-Sacro Cuore di Negrar, 37024 Verona, Italy

15. Medical Oncology Unit, Department of Human Pathology “G. Barresi”, University of Messina, 98122 Messina, Italy

16. Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, 90133 Palermo, Italy

17. Diabetology, Careggi University Hospital, University of Florence, 50134 Florence, Italy

18. Department of Clinical and Experimental Medicine, Endocrinology Section, University of Catania, 95124 Catania, Italy

19. Medical Oncology Division, Breast Unit, Senatore Antonio Perrino Hospital, ASL Brindisi, 72100 Brindisi, Italy

20. Endocrinology, Diabetology and Andrology Unit, Department of Clinical Medicine and Surgery, Federico II University of Naples, 80138 Naples, Italy

21. UNESCO Chair, Education for Health and Sustainable Development, Federico II University, 80131 Naples, Italy

22. Department of Medicine, Section of Diabetes and Metabolic Diseases, University of Padova, 35122 Padova, Italy

23. Diabetes Unit, Livorno Hospital, 57100 Livorno, Italy

Abstract

There is increasing evidence of the role of endocrine disruptors (EDs) derived from commonly employed compounds for manufacturing and processing in altering hormonal signaling and function. Due to their prolonged half-life and persistence, EDs can usually be found not only in industrial products but also in households and in the environment, creating the premises for long-lasting exposure. Polybrominated diphenyl ethers (PBDEs) are common EDs used in industrial products such as flame retardants, and recent studies are increasingly showing that they may interfere with both metabolic and oncogenic pathways. In this article, a multidisciplinary panel of experts of the Italian Association of Medical Diabetologists (AMD), the Italian Society of Diabetology (SID), the Italian Association of Medical Oncology (AIOM), the Italian Society of Endocrinology (SIE) and the Italian Society of Pharmacology (SIF) provides a review on the potential role of PBDEs in human health and disease, exploring both molecular and clinical aspects and focusing on metabolic and oncogenic pathways.

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Link

https://www.mdpi.com/2072-6694/15/17/4237/pdf

Reference105 articles.

1. Environmental Endocrine-Disrupting Chemical Exposure: Role in Non-Communicable Diseases;Kumar;Front. Public Health,2020

2. Exposure Pathways, Levels and Toxicity of Polybrominated Diphenyl Ethers in Humans: A Review;Wu;Environ. Res.,2020

3. European Commission (2011). DIRECTIVE 2011/65/EU of the European Parliament and of the Council of 8 June 2011—ROHS. Off. J. Eur. Union, 54, 88–110.

4. PBDEs in the Marine Environment: Sources, Pathways and the Role of Microplastics;Turner;Environ. Pollut.,2022

5. Global PBDE Contamination in Cetaceans. A Critical Review;Bartalini;Environ. Pollut.,2022